View highlights and coverage from leading international Ophthalmology congresses
Jesse Pelletier (Ocean Ophthalmology Group, North Miami Beach, FL, USA) discusses the role of the antiseptic povidone-iodine (PVP-I), which is now routinely employed and will play a greater role in the future of healthcare, particularly in the COVID-19 era. Questions: 1. Tell us about infection control in your office during this pandemic and where povidone-iodine […]
Ramin Khoramnia (University Eye Clinic Heidelberg, Heidelberg, Germany) discusses imitations of current treatment options for neovascular age-related macular degeneration, gives an overview of faricimab, its dosing regimen and its mechanism of action and discusses the major efficacy and safety findings of the STAIRWAY study, which were presented at WOC 2020. 1. What are the limitations […]
Matteo Piovella (Italian Society of Ophthalmology, Roma, Italy) discusses the practical benefits the IC-8 small aperture intraocular lens and its mechanism of action, and the major findings of his study, which were presented at the World Ophthalmology Congress 2020. 1. What are the practical benefits of the IC-8 compared with other commercially available IOLs? (0:05) […]
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also our way of life. The rate and distribution of the SARS-CoV-2 virus, despite […]
Matteo Piovella (Italian Society of Ophthalmology, Roma, Italy) gives an overview of the IC-8 small aperture intraocular lens and its mechanism of action. 1. Please could you give us a brief overview of the design of the IC-8 small aperture intraocular lens (IOL) and its mechanism of action? (0:04) Disclosures: Matteo Piovella has no financial […]
Emilio Torres-Netto (CABMM, University of Zürich, Zürich, Switzerland) discussed the outcomes of his 10-year study of corneal cross-linking for progressive keratoconus, adverse events and the impact of the findings on clinical practice. 1. What were the outcomes of your study of 10-year outcomes of corneal cross-linking for progressive keratoconus? (0:04) 2. What adverse effects were […]
Emilio Torres-Netto (CABMM, University of Zürich, Zürich, Switzerland) shares his thoughts on the rationale of corneal cross-linking in progressive keratoconus and the reasons for the lack of long-term data on corneal cross-linking to date. 1. What is the rationale for corneal cross-linking in progressive keratoconus? (0:09) 2. Before your study, how much long-term data on […]
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
John Hovanesian (Harvard Eye Associates, Laguna Hills, CA, USA) discusses challenges in the intraocular lens (IOL) market, some of the exciting IOLs to have emerged recently, and his thoughts on choosing the best option for patients and the responsibility of the ophthalmic surgen. 1. Could you briefly introduce yourself and give us an overview of […]
Get the latest clinical insights from touchOPHTHALMOLOGY
